0
Spring Bank Pharmaceuticals, Inc.
- 11-50 Employees
- Based in Hopkinton, Massachusetts
Spring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapeutics using small molecule nucleic acid hybrid (SMNH) chemistry platform. The company's lead SMNH product candidate is inarigivir soproxil, for the treatment of chronic hepatitis B virus (HBV). It is also developing SMNH product candidates, including STimulator…More
Spring Bank Pharmaceuticals, Inc.
Most Recent Responsibility Report
MOST RECENT
Request Information
Spring Bank Pharmaceuticals, Inc. does not currently have any reports on ResponsibilityReports.co.uk. Click the button below to be notified when financial info becomes available.
Our service enables potential investors to review the most recent and archived Spring Bank Pharmaceuticals, Inc. Sustainability Report, Spring Bank Pharmaceuticals, Inc. Corporate Social Responsibility Report, Spring Bank Pharmaceuticals, Inc. CSR Report, Spring Bank Pharmaceuticals, Inc. Corporate Responsibility, Spring Bank Pharmaceuticals, Inc. CR Report, Spring Bank Pharmaceuticals, Inc. Citizenship Report, Spring Bank Pharmaceuticals, Inc. ESG Report, and Spring Bank Pharmaceuticals, Inc. Environmental Report online.